SAFECODE DRUG TECHNOLOGIES CORP.: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $0
- Net Income/Loss (FY2012)
- -$2.1M
- Total Assets (FY2012)
- $174.3K
- Total Equity (FY2012)
- $112.7K
- Cash Flows from Operating Activities (FY2012)
- -$98.1K
Source: SAFECODE DRUG TECHNOLOGIES CORP. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
